Redhill Drug Patent Portfolio
Redhill owns 1 orange book drug protected by 7 US patents Given below is the list of Redhill's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11878011 | Method for eradicating Helicobacter pylori infection in patients regardless of body mass index | 27 May, 2042 | Active |
| US10238606 | Pharmaceutical compositions for the treatment of Helicobacter pylori | 12 Feb, 2034 | Active |
| US11135172 | Rifabutin-based compositions and methods for treating Helicobacter pylori infection | 12 Feb, 2034 | Active |
| US11931463 | All-in-one fixed-dose combination for treating Helicobacter pylori infection | 12 Feb, 2034 | Active |
| US9050263 | Pharmaceutical compositions for the treatment of Helicobacter pylori | 12 Feb, 2034 | Active |
| US9498445 | Pharmaceutical compositions for the treatment of Helicobacter pylori | 12 Feb, 2034 | Active |
| US9603806 | Pharmaceutical compositions for the treatment of Helicobacter pylori | 12 Feb, 2034 | Active |
Latest Legal Activities on Redhill's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Redhill.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 08 May, 2024 | US9498445 |
|
Recordation of Patent Grant Mailed
Critical
| 19 Mar, 2024 | US11931463 |
|
Email Notification
Critical
| 19 Mar, 2024 | US11931463 |
| Recordation of Patent eGrant | 19 Mar, 2024 | US11931463 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 19 Mar, 2024 | US11931463 |
| Mail Patent eGrant Notification | 19 Mar, 2024 | US11931463 |
| Patent eGrant Notification | 19 Mar, 2024 | US11931463 |
|
Email Notification
Critical
| 29 Feb, 2024 | US11931463 |
|
Issue Notification Mailed
Critical
| 28 Feb, 2024 | US11931463 |
|
Application Is Considered Ready for Issue
Critical
| 09 Feb, 2024 | US11931463 |
| Dispatch to FDC | 09 Feb, 2024 | US11931463 |
|
Issue Fee Payment Verified
Critical
| 08 Feb, 2024 | US11931463 |
|
Issue Fee Payment Received
Critical
| 08 Feb, 2024 | US11931463 |
| Recordation of Patent eGrant | 23 Jan, 2024 | US11878011 |
|
Email Notification
Critical
| 23 Jan, 2024 | US11878011 |
Redhill's Family Patents
Redhill drugs have patent protection in a total of 24 countries. It's US patent count contributes only to 29.4% of its total global patent coverage. Click
below to unlock the full patent family tree.
Redhill Drug List
Given below is the complete list of Redhill's drugs and the patents protecting them.
1. Talicia
Talicia is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11878011 | Method for eradicating Helicobacter pylori infection in patients regardless of body mass index |
27 May, 2042
(17 years from now)
| Active |
| US10238606 | Pharmaceutical compositions for the treatment of Helicobacter pylori |
12 Feb, 2034
(8 years from now)
| Active |
| US11135172 | Rifabutin-based compositions and methods for treating Helicobacter pylori infection |
12 Feb, 2034
(8 years from now)
| Active |
| US11931463 | All-in-one fixed-dose combination for treating Helicobacter pylori infection |
12 Feb, 2034
(8 years from now)
| Active |
| US9050263 | Pharmaceutical compositions for the treatment of Helicobacter pylori |
12 Feb, 2034
(8 years from now)
| Active |
| US9498445 | Pharmaceutical compositions for the treatment of Helicobacter pylori |
12 Feb, 2034
(8 years from now)
| Active |
| US9603806 | Pharmaceutical compositions for the treatment of Helicobacter pylori |
12 Feb, 2034
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Talicia's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List